Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria.
Merlotti A, Mazzola R, Alterio D, Alongi F, Bacigalupo A, Bonomo P, Maddalo M, Russi EG, Orlandi E. Merlotti A, et al. Among authors: maddalo m. Crit Rev Oncol Hematol. 2017 Mar;111:20-30. doi: 10.1016/j.critrevonc.2017.01.008. Epub 2017 Jan 17. Crit Rev Oncol Hematol. 2017. PMID: 28259292 Review.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Paganelli C, Majorana A, Gastaldi G, Bossi P, Berruti A, Pavanato G, Nicolai P, Maroldi R, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: maddalo m. Crit Rev Oncol Hematol. 2016 Jan;97:131-42. doi: 10.1016/j.critrevonc.2015.08.010. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2016. PMID: 26318095 Review.
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
Magrini SM, Buglione M, Corvò R, Pirtoli L, Paiar F, Ponticelli P, Petrucci A, Bacigalupo A, Crociani M, Lastrucci L, Vecchio S, Bonomo P, Pasinetti N, Triggiani L, Cavagnini R, Costa L, Tonoli S, Maddalo M, Grisanti S. Magrini SM, et al. Among authors: maddalo m. J Clin Oncol. 2016 Feb 10;34(5):427-35. doi: 10.1200/JCO.2015.63.1671. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644536 Clinical Trial.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Bossi P, Majorana A, Gastaldi G, Berruti A, Trippa F, Nicolai P, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: maddalo m. Crit Rev Oncol Hematol. 2016 Jun;102:47-54. doi: 10.1016/j.critrevonc.2016.03.012. Epub 2016 Mar 11. Crit Rev Oncol Hematol. 2016. PMID: 27061883 Review.
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Alongi F, Arcangeli S, Ramella S, Giaj-Levra N, Borghetti P, D'angelillo R, Ricchetti F, Maddalo M, Mazzola R, Trovò M, Russi E, Magrini SM; on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO). Alongi F, et al. Among authors: maddalo m. Expert Rev Anticancer Ther. 2017 Feb;17(2):157-165. doi: 10.1080/14737140.2017.1273111. Epub 2017 Jan 5. Expert Rev Anticancer Ther. 2017. PMID: 27984919 Review.
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Buglione M, et al. Among authors: maddalo m. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):462-472. doi: 10.1016/j.ijrobp.2016.10.011. Epub 2016 Oct 20. Int J Radiat Oncol Biol Phys. 2017. PMID: 27986347 Clinical Trial.
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO).
Maddalo M, Bonomo P, Belgioia L, Bacigalupo A, Donato V, Alterio D, Orlandi E, Argenone A, Merlotti A, Musio D, Trignani M, Ursino S, Arcangeli S, Furlan C, Osti MF; Italian Association of Radiation Oncology (AIRO). Maddalo M, et al. Eur Arch Otorhinolaryngol. 2018 Feb;275(2):561-567. doi: 10.1007/s00405-017-4853-8. Epub 2017 Dec 26. Eur Arch Otorhinolaryngol. 2018. PMID: 29279949
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
Orlandi E, Bonomo P, Ferella L, D'Angelo E, Maddalo M, Alterio D, Infante G, Bacigalupo A, Argenone A, Iacovelli NA, Desideri I, Meduri B, Triggiani L, Volpe S, Belgioia L, Dionisi F, Romanello DA, Fallai C, Miceli R. Orlandi E, et al. Among authors: maddalo m. Head Neck. 2019 Oct;41(10):3684-3692. doi: 10.1002/hed.25890. Epub 2019 Jul 29. Head Neck. 2019. PMID: 31355972
53 results